England’s NICE To ‘Explore’ Severity Modifier Changes As Cost-Effectiveness Threshold Branded ‘Ridiculous’

 
• By Eliza Slawther
  
Helen Knight, Koonal Shah, Chris Sampson, Lorna Dunning and Victoria Jordan at the NICE annual conference 2025 (Norstella)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Conferences